Tag: drugs

New drug shows heart benefits for muscular dystrophy patients
Patient Briefs

New drug shows heart benefits for muscular dystrophy patients

An experimental drug shows promise in protecting heart function for muscular dystrophy patients by reducing...

06/08/2026
User Blocked After Violation of Platform Policies
Gene Therapy

User Blocked After Violation of Platform Policies

Bispecific antibodies are emerging immunotherapy for relapsed lymphoma and leukemia, offering a viable option when...

20/07/2026
Website blocks users with error message
Gene Therapy

Website blocks users with error message

Heart failure management is shifting as pharmacists take on a larger role. Discover how they...

18/07/2026
User Blocked After Policy Violation
Trial Moves

User Blocked After Policy Violation

Proton pump inhibitors may reduce the benefit of durvalumab consolidation after chemoradiotherapy for unresectable stage...

User Account Blocked by Social Media Platform
Patient Briefs

User Account Blocked by Social Media Platform

GLP-1 receptor agonists can interact with oral chemotherapy, jeopardizing treatment effectiveness for diabetes and weight...

17/07/2026
Web users blocked from certain sites
Patient Briefs

Web users blocked from certain sites

FDA approves Leqembi home administration. Learn about the new starting dosage regimen for subcutaneous lecanemab...

14/07/2026
User access denied after system block
Gene Therapy

User access denied after system block

Learn why bispecific T-cell therapy for multiple myeloma may face access restrictions and how patient...

11/07/2026
New drug offers hope for tough-to-treat high blood pressure
Patient Briefs

New drug offers hope for tough-to-treat high blood pressure

A groundbreaking drug for resistant hypertension offers hope to patients unresponsive to standard treatments, targeting...

06/07/2026
Menin inhibitors show promise in AML treatment
Patient Briefs

Menin inhibitors show promise in AML treatment

Menin inhibitors offer new hope for AML treatment by targeting molecular drivers in 40% of...

30/06/2026